Yüklüyor......
Effect of route of administration of human recombinant Factor VIII on its immunogenicity in Hemophilia A mice
Factor VIII is a multi-domain glycoprotein and is an essential cofactor in the blood coagulation cascade. Its deficiency or dysfunction causes Hemophilia A, a bleeding disorder. Replacement using exogenous recombinant Factor VIII (FVIII) is the first line of therapy for Hemophilia A. Immunogenicity,...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2796435/ https://ncbi.nlm.nih.gov/pubmed/19499565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.21765 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|